Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Condition:   Persistent Asthma Interventions:   Combination Product: fluticasone/formoterol k-haler (medium strength);   Combination Product: Standard of care (ICs/LABA high strength) Sponsors:   Mundipharma Pharmaceuticals S.L.;   Alpha Bioresearch S.L.;   Dynamic Solutions Not yet recruiting

Source: ClinicalTrials.gov - February 17, 2020 Category: Research Source Type: clinical trials